The optimal ghk-cu protocol depends entirely on the therapeutic goal, distinguishing between systemic effects and localized treatment
This finding alone should give any researcher pause
At the 3.0 mg daily dose, liraglutide produced average weight losses on the order of ~8% in pivotal trials (SCALE program), with additional benefits in glycemic measures and cardiometabolic risk markers
Peptide degradation from poor storage, incorrect reconstitution, or simply underdosed product is a bigger confound in this space than most discussions acknowledge
Its important because vitamin B12 is integral for many functions, including optimized cell reproduction, blood formation, protein, and tissue synthesis
Thyroid dysfunction, insulin resistance, polycystic ovary syndrome, certain medications (like corticosteroids or some antidepressants), and hormonal imbalances can all impair weight loss response to semaglutide